Rosen Law Firm announces a class action lawsuit for purchasers of American Depositary Shares of Mereo BioPharma Group plc, with a lead plaintiff deadline of April 6, 2026. Investors may be entitled to compensation due to misleading statements regarding the company's Phase 3 clinical trials.
Related articles
Press ReleaseMay 8, 2026
West Enclave Merger Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing May 13, 2026
May 8, 2026
Press ReleaseMay 8, 2026
Shreya Acquisition Group Announces Closing of $110 Million Initial Public Offering (Including Partial Exercise of Over-Allotment Option)
May 8, 2026
Press ReleaseMay 8, 2026
Con Edison Announces $2 Billion At-The-Market (ATM) Equity Offering Program
May 8, 2026
← Back to all articles
Generated by Yeal